A Study Of Corticosteroid On Postoperative Pain After Ureteroscopy For Urinary Calculi

Part of paid clinical trials in Scottsdale, Arizona.

Sponsor
Mayo Clinic
Study ID
NCT07223580
Phase
PHASE4
Status
Recruiting

Conditions

  • Post Operative Pain
  • Ureteroscopy

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Corticosteroid — DRUG
    In addition to the standard of care postoperative ureteroscopy medication, participants will be given prednisone 25 mg orally, once a day for 5 days post-surgery.
  • Placebo — OTHER
    In addition to the standard of care postoperative ureteroscopy medication, participants will be given a placebo pill orally, once a day for 5 days post-surgery.

Study Details

The purpose of this research is to evaluate if corticosteroid (prednisone) after ureteroscopy and placement of the stent will help alleviate postoperative pain control in addition to other normal postoperative pain medications

Key Dates

Start date
Jan 23, 2026
Status verified
Jan 2026
Primary completion
Jan 1, 2027
Completion
Dec 1, 2027

Study Design

Enrollment
90 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Standard of care plus Corticosteroid
    Participants will receive standard of care postoperative ureteroscopy medication, with the addition of prednisone 25 mg.
  • Placebo Comparator: Standard of Care
    Participants will receive standard of care postoperative ureteroscopy medication, with the addition of a placebo pill.

Primary Outcome Measure

Change in Visual Analog Scale Pain Score [ Time Frame: Baseline, Day 1 (Post-operatively), Day 2, Day 3 ]

Central Contacts

  • Rev V. Vilasan Shylaja
    480-574-1466

Locations (1)

FacilityCityStateZIPSite coordinators
Mayo Clinic in ArizonaScottsdaleArizona85259
Rev V. Vilasan Shylaja
480-574-1466
Karen L. Stern, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Scottsdale, AZ

Related Studies